• Latest Posts

Berlin Biotech Raises €24M to Progress Septic Shock Candidate to Clinic

Series A Boost for Swedish Biotech’s Sickle Cell Disease Treatment

Gene Therapy For Beta-Thalassemia Could Eliminate Need for Transfusions

This Gene Therapy for Hemophilia Can Reduce Bleeding by 70%

CRISPR Therapeutics Plans First CRISPR/Cas9 Clinical Trial in Europe for 2018

ADVERTISEMENT

Ablynx Launches $175M IPO on Wall Street After Phase III Success

Belgian Biotech Breaks New Ground in Fight Against Life-Threatening Blood Disorder

A €344M Partnership will Develop Bicycle Drugs for Hemophilia

Interview 22 May 2017

Meet the New CEO of the Dutch Biotech Making a Cure for Blood Cancer

Curing Cancer with Safer Transplants: UK Approval to start Clinical Trials

Fighting for the next Asthma Blockbuster: Italy gets in the way of Novartis

ADVERTISEMENT